SEC Form 4 · accession 0001615774-17-004886
ANAVEX LIFE SCIENCES CORP. · AVXL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher U Missling
Officer — President and CEO · Director
Period of report
Aug 31, 2017
Accepted (ET)
Aug 31, 2017 · 2:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001314052
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 31, 2017 | P | 375 | $4.48 | A | 1,006,250 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The purchase reported in this form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017.